BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 23686938)

  • 41. Implementing methods to improve perioperative hemostasis in the surgical and trauma settings.
    Neveleff DJ; Kraiss LW; Schulman CS
    AORN J; 2010 Nov; 92(5):S1-15. PubMed ID: 21040810
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Haemostatic sealants in nephron-sparing surgery: what surgeons need to know.
    Dalpiaz O; Neururer R; Bartsch G; Peschel R
    BJU Int; 2008 Dec; 102(11):1502-8. PubMed ID: 18990159
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of the Hemostatic Efficacy of Two Powdered Topical Absorbable Hemostats Using a Porcine Liver Abrasion Model of Mild to Moderate Bleeding.
    MacDonald MH; Tasse L; Wang D; Zhang G; De Leon H; Kocharian R
    J Invest Surg; 2021 Nov; 34(11):1198-1206. PubMed ID: 32928005
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Absorbable hemostatic agents.
    Gabay M
    Am J Health Syst Pharm; 2006 Jul; 63(13):1244-53. PubMed ID: 16790576
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hemostatic agents and instruments in laparoscopic renal surgery.
    Msezane LP; Katz MH; Gofrit ON; Shalhav AL; Zorn KC
    J Endourol; 2008 Mar; 22(3):403-8. PubMed ID: 18355135
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fibrin sealant in the United States: clinical use at the University of Virginia.
    Spotnitz WD
    Thromb Haemost; 1995 Jul; 74(1):482-5. PubMed ID: 8578510
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alternative and topical approaches to treating the massively bleeding patient.
    Kulkarni R
    Clin Adv Hematol Oncol; 2004 Jul; 2(7):428, 431. PubMed ID: 16163216
    [No Abstract]   [Full Text] [Related]  

  • 48. Clinical benefits and risk analysis of topical hemostats: a review.
    Tomizawa Y
    J Artif Organs; 2005; 8(3):137-42. PubMed ID: 16235029
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinician reported ease of use for a novel fibrin sealant patch for hemostasis: results from four randomized controlled trials.
    Corral M; Ferko N; Hollmann S; Hogan A; Jamous N; Batiller J; Shen J
    Curr Med Res Opin; 2016; 32(2):367-75. PubMed ID: 26636489
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study.
    Rousou J; Levitsky S; Gonzalez-Lavin L; Cosgrove D; Magilligan D; Weldon C; Hiebert C; Hess P; Joyce L; Bergsland J
    J Thorac Cardiovasc Surg; 1989 Feb; 97(2):194-203. PubMed ID: 2464722
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in children undergoing adenoidectomy.
    Mathiasen RA; Cruz RM
    Otolaryngol Head Neck Surg; 2004 Nov; 131(5):601-5. PubMed ID: 15523433
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adverse effects of fibrin sealants in thoracic surgery: the safety of a new fibrin sealant: multicentre, randomized, controlled, clinical trial.
    Cardillo G; Carleo F; Carbone L; De Massimi AR; Lococo A; Santini PF; Janni A; Gonfiotti A
    Eur J Cardiothorac Surg; 2012 Mar; 41(3):657-62. PubMed ID: 22219405
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potent Hemostatic Efficacy of a Novel Recombinant Fibrin Sealant Patch (KTF-374) in Rabbit Bleeding Models.
    Miyabashira Tanaka S; Imamura T; Fujimoto M; Ohno A; Kobayashi T; Shinya N
    J Invest Surg; 2019 Apr; 32(3):257-261. PubMed ID: 29260920
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A safety review of topical bovine thrombin-induced generation of antibodies to bovine proteins.
    Ofosu FA; Crean S; Reynolds MW
    Clin Ther; 2009 Apr; 31(4):679-91. PubMed ID: 19446142
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improving outcomes through the use of surgical sealants for anastomotic sealing during cardiovascular surgery.
    DeAnda A; Elefteriades JA; Hasaniya NW; Lattouf OM; Lazzara RR
    J Card Surg; 2009; 24(3):325-33. PubMed ID: 19438792
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Use of topical hemostatic preparations in surgery].
    Pavlovskiĭ DP; Baluda VP; Sushkevich GP
    Klin Khir (1962); 1976 Aug; (8):66-72. PubMed ID: 787634
    [No Abstract]   [Full Text] [Related]  

  • 57. Fibrin Sealants: Challenges and Solutions.
    Beudert M; Gutmann M; Lühmann T; Meinel L
    ACS Biomater Sci Eng; 2022 Jun; 8(6):2220-2231. PubMed ID: 35610572
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use and Efficacy of Hemostats in Neurosurgery.
    Signorelli F; Montano N
    Surg Technol Int; 2020 Nov; 37():414-419. PubMed ID: 32944921
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The coagulation cascade and surgical hemostasis. Introduction.
    Voils SA
    Pharmacotherapy; 2009 Jul; 29(7 Pt 2):1S. PubMed ID: 19558277
    [No Abstract]   [Full Text] [Related]  

  • 60. Fibrin sealants in surgical practice: An overview.
    Jackson MR
    Am J Surg; 2001 Aug; 182(2 Suppl):1S-7S. PubMed ID: 11566470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.